Trial Profile
Efficacy and safety of low dose dasatinib in elderly patients with chronic myeloid leukemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Aug 2016
Price :
$35
*
At a glance
- Drugs Dasatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Adverse reactions; Therapeutic Use
- 31 Aug 2016 New trial record